Data as of Jul 23
| +0.10 / +0.69%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 14.50, with a high estimate of 22.00 and a low estimate of 7.00. The median estimate represents a -0.75% decrease from the last price of 14.61.
The current consensus among 2 polled investment analysts is to Buy stock in Osiris Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.